REGN vs UMAC · P/E 14, rev $4.29B vs rev $11.2M
Regeneron Pharmaceuticals Inc (REGN) versus Unusual Machines, Inc. (UMAC) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Unusual Machines, Inc. (UMAC) is a computer hardware company listed on US.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported UMAC revenue for 2025-12-31 was $11.2M. Net income was -$19.2M. Revenue was up 101.2% from 2024-12-31 to 2025-12-31. UMAC currently screens at market cap $219.2M.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. UMAC currently screens at market cap $219.2M.
Not investment advice. Open the REGN and UMAC stock pages for the full models.
Not investment advice.